Baran, B. Et Al. 2013. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B. 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , (Washington, Kiribati).

Baran, B., Soyer, O. M., Ormeci, A., Gokturk, S., Evirgen, S., Akyuz, F., ... Karaca, C.(2013). The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B . 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati

Baran, Bülent Et Al. "The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B," 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 2013

Baran, Bülent Et Al. "The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B." 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , Washington, Kiribati, 2013

Baran, B. Et Al. (2013) . "The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B." 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , Washington, Kiribati.

@conferencepaper{conferencepaper, author={Bülent BARAN Et Al. }, title={The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B}, congress name={64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases}, city={Washington}, country={Kiribati}, year={2013}}